Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 17, 2026 | UMR (UnitedHealthcare) | Spevigo (Spesolimab-Sbzo) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Somatostatin Analogs | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Sodium Hyaluronate | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Sleep Studies | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Skyrizi (Risankizumab-Rzaa) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Skin and Soft Tissue Substitutes | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Sinus Surgeries and Interventions | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Simponi Aria (Golimumab) Injection for Intravenous Infusion | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Sensory Integration Therapy and Auditory Integration Training | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Self-Administered Medications | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Screening Colonoscopy Procedures – Site of Service | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Scenesse (Afamelanotide) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Saphnelo (Anifrolumab-Fnia) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Sacroiliac Joint Interventions | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Sacral Nerve Stimulation for Urinary and Fecal Indications | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Ryplazim (Plasminogen, Human-Tvmh) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Roctavian (Valoctocogene Roxaparvovec-Rvox) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | RNA-Targeted Therapies (Amvuttra and Onpattro) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Rituximab (Riabni, Rituxan, Ruxience, & Truxima) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Rhinoplasty and Other Nasal Procedures | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Review at Launch for New to Market Medications | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Respiratory Pathogen Nucleic Acid Detection Testing | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Respiratory Interleukin-5 Inhibitor | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Repository Corticotropin Injections | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Rebyota (Fecal Microbiota, Live-Jslm) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Reblozyl (Luspatercept-Aamt) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Radiation Therapy: Fractionation, Image-Guidance, and Special Services | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Qalsody (Tofersen) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Provider Administered Drugs – Site of Care | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Provider Administered Drugs – Preferred Products | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Proton Beam Radiation Therapy | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Prostate Surgeries and Interventions | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Prolotherapy and Platelet Rich Plasma Therapies | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Private Duty Nursing Services | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Preventive Vaccines (Immunizations) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Preventive Care Services | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Preimplantation Genetic Testing and Related Services | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Pneumatic Compression Devices | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Plagiocephaly and Craniosynostosis Treatment | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Pharmacogenetic Panel Testing | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Percutaneous Vertebroplasty and Kyphoplasty | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Percutaneous Patent Foramen Ovale (PFO) Closure | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Percutaneous Neuroablation for Pancreatic Cancer Pain, Severe Cancer Pain, and Trigeminal Neuralgia | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Parsabiv (Etelcalcetide) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Papzimeos (Zopapogene Imadenovec-Drba) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Panniculectomy Surgery | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Oxlumo (Lumasiran) and Rivfloza (Nedosiran) | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Outpatient Surgical Procedures – Site of Service | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Orthognathic (Jaw) Surgery | Criteria changed |
| May 17, 2026 | UMR (UnitedHealthcare) | Orencia (Abatacept) Injection for Intravenous Infusion | Criteria changed |